Wave Life Sciences Stock Analysis

Wave Stock Analysis Notes

About 15.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 0.65. Wave Life Sciences had not issued any dividends in recent years. Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. The company was incorporated in 2012 and is based in Singapore. Wave Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 235 people. For more information please call MBA MD at 65 6236 3388 or visit https://wavelifesciences.com.

Wave Life Sciences Investment Alerts

Wave Life Sciences Upcoming and Recent Events

Wave Largest EPS Surprises

View All Earnings Estimates

Wave Life Environmental, Social, and Governance (ESG) Scores

Wave Stock Institutional Investors

Note, although Wave Life's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Wave Market Capitalization

The company currently falls under 'Mid-Cap' category with a total capitalization of 1.18 B.

Wave Profitablity

The company has Net Profit Margin of (1.12) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (7.41) %, which entails that for every $100 of revenue, it lost $7.41.

Management Efficiency

Wave Life Sciences has Return on Asset of (0.2833) % which means that on every $100 spent on assets, it lost $0.2833. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.8651) %, meaning that it generated no profit with money invested by stockholders. Wave Life's management efficiency ratios could be used to measure how well Wave Life manages its routine affairs as well as how well it operates its assets and liabilities. As of November 17, 2025, Return On Tangible Assets is expected to decline to -0.29. In addition to that, Return On Capital Employed is expected to decline to -0.48. At present, Wave Life's Fixed Asset Turnover is projected to increase slightly based on the last few years of reporting. The current year's Asset Turnover is expected to grow to 0.32, whereas Other Assets are forecasted to decline to about 4.1 M.

Technical Drivers

As of the 17th of November 2025, Wave Life maintains the Standard Deviation of 4.57, mean deviation of 3.07, and Market Risk Adjusted Performance of (0.16). Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Wave Life Sciences, as well as the relationship between them. Please check out Wave Life Sciences risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Wave Life Sciences is priced fairly, providing market reflects its latest price of 7.08 per share. Given that Wave Life Sciences has information ratio of (0.07), we strongly advise you to confirm Wave Life Sciences's prevalent market performance to make sure the company can sustain itself at a future point.

Wave Life Sciences Price Movement Analysis

Wave Life Sciences Insider Trading Activities

Wave Life Outstanding Bonds

Wave Life Predictive Daily Indicators

Wave Life Corporate Filings

Wave Life Forecast Models

Wave Life's time-series forecasting models are one of many Wave Life's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Wave Life's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Wave Life prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Wave shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Wave Life. By using and applying Wave Stock analysis, traders can create a robust methodology for identifying Wave entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Wave analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Wave analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Wave Life Sciences stock analysis indicators help investors evaluate how Wave Life stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Wave Life shares will generate the highest return on investment. By understating and applying Wave Life stock analysis, traders can identify Wave Life position entry and exit signals to maximize returns.

When running Wave Life's price analysis, check to measure Wave Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Wave Life is operating at the current time. Most of Wave Life's value examination focuses on studying past and present price action to predict the probability of Wave Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Wave Life's price. Additionally, you may evaluate how the addition of Wave Life to your portfolios can decrease your overall portfolio volatility.